174 related articles for article (PubMed ID: 22633343)
1. Combined use of ¹²³I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study.
Kim JS; Oh YS; Kim YI; Yang DW; Chung YA; You IeR; Lee KS
Arch Gerontol Geriatr; 2013; 56(1):124-8. PubMed ID: 22633343
[TBL] [Abstract][Full Text] [Related]
2. Persistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter Imaging.
Hong JY; Sunwoo MK; Oh JS; Kim JS; Sohn YH; Lee PH
PLoS One; 2016; 11(6):e0157410. PubMed ID: 27294367
[TBL] [Abstract][Full Text] [Related]
3. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
Uyama N; Otsuka H; Shinya T; Otomi Y; Harada M; Sako W; Izumi Y; Kaji R; Watanabe Y; Takashi S; Kunikane Y
Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
[TBL] [Abstract][Full Text] [Related]
4. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
5. Dual-phase
Kim MS; Park DG; An YS; Yoon JH
Eur J Neurol; 2023 Feb; 30(2):344-352. PubMed ID: 36288409
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopamine activity and myocardial
Oh YS; Kim JS; Yoo SW; Hwang EJ; Lyoo CH; Lee KS
Parkinsonism Relat Disord; 2019 Jun; 63():156-161. PubMed ID: 30796009
[TBL] [Abstract][Full Text] [Related]
7. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
[TBL] [Abstract][Full Text] [Related]
8. Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
Chung SJ; Yoo HS; Moon H; Oh JS; Kim JS; Park YH; Hong JY; Ye BS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):169-174. PubMed ID: 28912301
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis.
Tachibana K; Matsuura K; Shindo A; Matsuyama H; Ii Y; Taniguchi A; Tomimoto H
Intern Med; 2020; 59(4):485-490. PubMed ID: 32062624
[TBL] [Abstract][Full Text] [Related]
10. Combined use of dopamine transporter imaging (DAT-SPECT) and
Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
[TBL] [Abstract][Full Text] [Related]
11. Decreased thalamic monoamine availability in drug-induced parkinsonism.
Oh YS; Yoo SW; Lyoo CH; Kim JS
Sci Rep; 2022 Mar; 12(1):3749. PubMed ID: 35260679
[TBL] [Abstract][Full Text] [Related]
12.
Yang HJ; Park SH; Seo M; Weon YC; Kim Y
Neurotoxicology; 2018 Jan; 64():78-84. PubMed ID: 28259768
[TBL] [Abstract][Full Text] [Related]
13. Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors.
Novellino F; Arabia G; Bagnato A; Cascini GL; Salsone M; Nicoletti G; Messina D; Morelli M; Paglionico S; Giofrè L; Restuccia A; Torchia G; Condino F; Quattrone A
Mov Disord; 2009 Nov; 24(15):2242-8. PubMed ID: 19795467
[TBL] [Abstract][Full Text] [Related]
14. Association of plasma α-synuclein with cardiac
Park DG; Kang J; An YS; Chang J; Yoon JH
Neurosci Lett; 2022 Jan; 770():136399. PubMed ID: 34921912
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of combining
Niimi Y; Ito S; Murate K; Hirota S; Hikichi C; Ishikawa T; Maeda T; Nagao R; Shima S; Mizutani Y; Ueda A; Mutoh T
J Neurol Sci; 2017 Jun; 377():174-178. PubMed ID: 28477690
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach.
Südmeyer M; Antke C; Zizek T; Beu M; Nikolaus S; Wojtecki L; Schnitzler A; Müller HW
J Nucl Med; 2011 May; 52(5):733-40. PubMed ID: 21498527
[TBL] [Abstract][Full Text] [Related]
17. Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism.
Lee PH; Kim JS; Shin DH; Yoon SN; Huh K
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):372-4. PubMed ID: 16103041
[TBL] [Abstract][Full Text] [Related]
18. Impact of DAT-SPECT on Management of Patients Suspected of Parkinsonism.
Mirpour S; Turkbey EB; Marashdeh W; El Khouli R; Subramaniam RM
Clin Nucl Med; 2018 Oct; 43(10):710-714. PubMed ID: 30153144
[TBL] [Abstract][Full Text] [Related]
19. Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism.
Kim JS; Lee PH; Lee KS; Park JW; Kim YI; Chung YA; Kim SH; Kim SH; Kim J; Choi YY; Kim HT
Mov Disord; 2006 Nov; 21(11):1990-4. PubMed ID: 16991157
[TBL] [Abstract][Full Text] [Related]
20. Cognitive dysfunction in drug induced parkinsonism (DIP).
Kim YD; Kim JS; Chung SW; Song IU; Yang DW; Hong YJ; Kim YI; Ahn KJ; Kim HT; Lee KS
Arch Gerontol Geriatr; 2011; 53(2):e222-6. PubMed ID: 21163539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
